Abstract | Articular cartilage is a physiologically non-self-renewing avascular tissue with a singular cell type, the chondrocyte, which functions as the load-bearing surface of the arthrodial joint. Injury to cartilage often progresses spatiotemporally from the articular surface to the subchondral bone, leading to development of degenerative joint diseases such as osteoarthritis (OA). Although lacking intrinsic reparative ability, articular cartilage has been shown to contain a population of stem cells or progenitor cells, similar to those found in many other adult tissues, that are thought to be involved in the maintenance of tissue homeostasis. These so-called cartilage-derived stem/progenitor cells (CSPCs) have been observed in human, equine and bovine articular cartilage, and have been identified, isolated and characterized on the basis of expression of stem-cellrelated surface markers, clonogenicity and multilineage differentiation ability. However, the origin and functions of CSPCs are incompletely understood. We review here the current status of CSPC research and discuss the possible origin of these cells, what role they might have in cartilage repair, and their therapeutic potential in OA.
Introduction
In 1743, the anatomist William Hunter noted: "...from Hippocrates down to the present age, we shall find, that an ulcerated cartilage is universally allowed to be a trouble some disease... and that, when destroyed, it is never recov ered. "
1 Articular cartilage is matrixrich, hypocellular and vasculaturefree, a structure that enables it to function as a lubricating and loadbearing surface in the joints. Injury to cartilage often progresses spatiotemporally from the articu lar surface to the subchondral bone, leading to the develop ment of degenerative joint diseases such as osteoarthritis (OA). OA is characterized by progressive loss of articular cartilage, subchondral bone sclerosis, osteophyte forma tion and synovial inflammation; clinical symptoms include activity limitation and pain. 2 OA is the most common cause of mobility loss, severely affects quality of life, work pro ductivity and cost of health care, and is the most prevalent form of musculoskeletal disease worldwide. [3] [4] [5] Because of their ability to form multiple tissue types, stem cells are a promising candidate cell type for tissue regeneration, particularly for the repair of degenerated tissues, including articular cartilage. Although lacking intrinsic reparative ability, articular cartilage has been shown to contain a population of cells with progenitor like qualities, [6] [7] [8] [9] [10] [11] similar to populations of stem cells found in many other tissues. 12 These cartilagederived stem/ progenitor cells (CSPCs) have been observed in human, equine and bovine articular cartilage, and have been identified, isolated and characterized on the basis of their capacity for selfrenewal, expression of stemcellrelated surface markers, and ability to differentiate along multiple lineages. However, the origin and functions of these CSPCs are incompletely understood. In this Review, we focus on the current status of CSPC research and address the fol Cartilage stem/progenitor cells
Stem cells in a nonreparative tissue
Stem cells are characterized principally by their ability to selfrenew and differentiate along multiple lineages. Embryonic stem cells, derived from the inner cell mass of blastocysts, are termed pluripotent because of their ability to progress along the endodermal, mesodermal, and ectodermal lineages. 13 On the other hand, adult stem cells, such as mesenchymal stem cells (MSCs) and haemato poietic stem cells (HSCs), are usually referred to as multipotent, because of their more limited lineage differentiation abilities. 14, 15 Advances in the reprogram ming of adult somatic cells have generated induced pluri potent stem cells (iPSCs), which resemble embryonic stem cells in terms of their unlimited replicative activity, pluripotency and germline integrative ability. 16 During development, it is generally assumed that the potency of stem cells becomes more restricted, and that some stem cells can exist in certain tissues as quiescent progenitor cells. 17 Numerous investigations have shown that these tissuespecific stem cells are present, and that they are probably involved in the maintenance of tissue homeostasis, in many tissues. 12, 18, 19 area to form reparative cartilage, which usually consists of a structurally inferior fibrous tissue. 20 The existence of an endogenous population of progenitor or stem cells in articular cartilage that function as reparative cells, how ever, was considered questionable because articular car tilage is unable to heal effectively after injury. 13 The lack of a perichondrium and vasculature in articular cartilage also probably contribute to the nonreparative nature of this tissue, but neither transplantation of perichondrium nor connection of bone marrow with microfracture has been found to contribute to efficient articular carti lage repair. [21] [22] [23] [24] Nonetheless, recent studies have identi fied, isolated and characterized a population of stem or p rogenitor cells from articular cartilage. [6] [7] [8] [9] [10] [11] Characterization of CSPCs Although stem cells are probably present in most tissues, their isolation and verification are not easy tasks. In the case of HSCs, a welldefined combination of cellsurface antigens is required for cell tracing to identify the pheno type and function of different stem cell subpopulations. 25 For stem or progenitor cells in cartilage tissue, a defini tive biomarker is lacking, but a number of clues exist regarding their characteristics.
Chondrocytes, long considered the only cell type within articular cartilage, have been shown to quickly lose their ability to produce a cartilaginous extracellular matrix (ECM) after in vitro expansion, 26 a phenomenon referred to as chondrocyte dedifferentiation. However, in 2003, Barbero et al. 27 observed the presence of colonyforming cells in dedifferentiated adult human articular chondro cytes in culture; these cells had chondrogenic, osteogenic and adipogenic differentiation potential. The following year Alsalameh et al. 28 reported the presence of mesenchy mal progenitor cells in normal and osteoarthritic human articular cartilage, based on the coexpression of the cell surface markers CD105 (endoglin) and CD166 (activated leukocyte cell adhesion molecule), and that these cells were comparable to bonemarrowderived MSCs in terms of their capacity to differentiate into adipocytes or osteo cytes. Several independent research groups have since reported observations of stem or progenitor cells from human articular cartilage tissue. 8, [29] [30] [31] [32] [33] These cells were characterized according to properties of adult stem cells, such as selfrenewal capacity, multi lineage differentiation potential and the presence of a repertoire of MSCrelated surface markers, similar to the identifica tion of bonemarrowderived MSCs ( Figure 1 ). The self renewal capacity of the cells was verified on the basis of the colonyforming unit (CFU) test 7, 32 and the generation of side populations (as identified by Hoechst dye exclusion on flow cytometry). 6, 30 The Archer group also reported longer telomere length and higher telomerase activity in the clonally derived cells, compared with chondrocytes isolated from the full depth of the articular cartilage, after many population doublings, 6 further corroborating their selfrenewal ability. Multilineage potency was established via osteogenic, chondrogenic and adipogenic differentia tion in vitro. 28 Furthermore, as a potential cell source for cartilage repair, articular cartilage progenitor cells were 6, 7, 8 Migratory activity of CSPCs has also been found in response to injury 31 Notch 1 (neurogenic locus notch homologue protein 1), 29, 36 and STRO1, 30 among others. Another characteristic stem cell behavior, migratory ability, was observed by two dif ferent groups: Koellings et al. 32 detected migratory chon drogenic progenitor cells in degenerated cartilage sites in latestage OA, and Seol and colleagues reported that chon drogenic progenitor cells emerged and migrated to the site of injury caused by blunt impact 31 or mild enzymatic insult to the ECM 37 in healthy cartilage explants. Taken together, these observations suggest that CSPCs exist in adult articu lar cartilage tissue and might have functional roles similar to other tissuespecific stem cells.
Origin of CSPCs

CSCs and CPCs in developing cartilage
The three types of cartilaginous tissue in human bodyhyaline cartilage, fibrocartilage and elastic cartilage-are distinguishable by the unique molecular composition and organization of their ECM; articular cartilage is the hyaline cartilage that covers the end of diarthro dial joints. Developmentally, most hyaline cartilage exists as a transitional stage tissue during embryonic skeletogenesis (Box 1).
The developmental origin of human CSPCs has not been welldefined because of a lack of stable markers for tracing their lineage, but some important clues are nevertheless available. Quintin et al. 7 reported the isola tion of cells capable of multilineage differentiation from human fetal femurs at weeks 14-16 of embryogenesis, and Wu et al. 38 used microdissection to identify differ ent subpopulations of cartilageforming cells in human embryonic limb buds. In the latter study, two cell sub populations present at weeks 5-6 were of particular interest: CD166 low/-CD73 -CD146 + cells, with the capa city to undergo multilineage differentiation, including chondro genesis; and CD166 low/-CD73 + CD146 low/-LIN -CD44 low cells, which were able to undergo only chondro genesis. 38 These findings suggest that at least two different sub populations of chondrogenic cells coexist in developing cartilage-a population of multipotent car tilage stem cells (CSCs) and a population of oligopotent chondrogenic cartilage progenitor cells (CPCs).
However, the definitive identification of CSCs and CPCs in human adult articular cartilage has remained elusive. This difficulty could be due not only to the lack of a welldefined marker to enable specific purifi cation of these cells, but also to the change in cellular phenotype upon isolation and monolayer expansion of both normal 39 and OA 40, 41 chondrocytes. In vitro culture has been shown to alter stem cell phenotype, and stem cell surface markers, such as Notch1 and STRO1, are not well maintained in monolayer cultures. 30, 39, 42, 43 Thus, although CSPCs in human cartilage are reported by dif ferent research groups, 8, 27, 28 as yet no single cellspecific surface marker is available to directly identify CSCs or CPCs, or distinguish them from each other, either in vitro or in vivo. 33 Mature articular cartilage has a zonal architecture (Box 2), with different zones characterized by variations in matrix biochemical composition 44 and cell distribution. 45 Cells with phenotypic and functional properties similar to mesenchymal stem cell or progenitor cell populations, such as those derived from bone marrow, have been detected mostly in the superficial zone of mature articu lar cartilage (Figure 2a) . 28 
Function of CSPCs in cartilage repair
In view of the 'stemlike' or 'progenitorlike' properties of CSPCs, it has been proposed that these cells probably have a role in cartilage injury and repair; 31,32 however, a major caveat is the distinctive inability of hyaline Box 1 | Cartilage formation during embryonic skeletogenesis Embryonic limb development begins with proliferation and condensation of limb mesenchymal cells, followed by their chondrogenic differentiation and production of a cartilaginous ECM to form the cartilage anlage, the model of the future long bone. 74 Partitioning of the cartilage anlage forms a noncartilaginous region known as the interzone, where a process of cavitation later results in the formation of the future joint cavity. The cartilage model is then replaced by bone from the center to the distal ends via the process of endochondral ossification. 75 As the interzone emerges, flattened cells appear on either side. 76, 77 These flattened cells become articular chondrocytes that reside at the surface of diarthrodial joints and give rise to permanent hyaline cartilage; 78, 79 postnatal reorganization forms the zonal structure that characterizes mature cartilage. 80 CPCs were first reported by Dowthwaite et al., 46 who identified them as a subpopulation of superficial zone cells for appositional growth of bovine articular cartilage that have enhanced affinity to fibronectin and expressed high level of Notch-1.
Abbreviations: CPC, cartilage progenitor cell; ECM, extracellular matrix; Notch-1, neurogenic locus notch homologue protein 1.
Box 2 | Zonal structure of mature articular cartilage
The superficial zone (tangential layer) consists of two to three layers of small, flattened chondrocytes arranged parallel to the surface that produce high quantities of a specific proteoglycan lubricant (proteoglycan 4, also known as lubricin). In the middle or transitional zone, chondrocytes are spherical; in the deep or radial zone, chondrocytes are enlarged and form columns perpendicular to the joint surface. In the middle and deep zones, the cartilage ECM is composed mainly of type II collagen, aggrecan and hyaluronan. Finally, in the calcified zone, chondrocytes are hypertrophic and embedded in a calcified ECM connected to the subchondral bone, separated from the uncalcified zone by a histologically distinct structure, the tidemark.
Abbreviation: ECM, extracellular matrix.
cartilage to selfrepair. In many other tissues, tissue specific stem cells have been shown to contribute to tissue renewal and homeostasis. In injured muscle fibre, for example, satellite cells contribute to both myofibre repair and satellite cell repopulation. 12 Although direct tracing of CSPCs has not been possible without a defini tive and consistent biomarker, a number of findings strongly suggest that CSPCs respond to tissue damage, as would be expected for a chondrogenic stemcell or progenitorcell population.
Given the lack of a universally accepted set of bio markers, most research groups have generally used the term 'CPCs' to define chondrogenic progenitor cells that respond to injury and migrate; 31,37,52,53 in one particular study, migratory cells from OA cartilage were termed 'CSPCs' . 32 As discussed earlier, the distinction between CSCs and CPCs in adult cartilage remains unclear; we have thus adopted the terminology of the original studies in this Review.
CPCs in response to injury
The emergence of CPCs in a healthy cartilage explant in response to a blunt mechanical impact or scratch injury was reported by Seol et al., 31 who observed the appearance, within the ECM surrounding the injury site after 7-14 days, of a migratory cell population that showed characteristics of chondrogenic progenitor cells. Furthermore, isolated CPCs seem to respond to the biological stimuli and changes that accompany joint injury, such as ECM degradation, blood infiltration and synovitis. For example, mild enzymatic insult to the cartilage ECM promoted CPCs migration in cultured articular cartilage explants. 37 The soluble factors released after injury are thought to initiate such migration, a hypothesis supported by the similar response of CPCs to deadcell debris and to medium conditioned by injured cartilage. 31 For example, high mobility group protein B1 (HMGB1) released by OA synoviocytes has been impli cated as a biochemical mediator of inflammation, acting in co operation with IL1β. 31, 54 Other soluble factors could also enhance the chemotactic activity of chondrocytes, such as insulinlike growth factor 1 (IGF1) in serum 55 and plateletderived growth factor (PDGF) 55, 56 in synovial fluid 57 or posttraumatic bleeding. 58, 59 Thus, migration of CPCs is likely to be regulated by multiple tissueinjury related signals. Interestingly, exposure to lowintensity pulsed ultrasound reportedly promotes migration of CPCs in cartilage explants, 52 suggesting that both chemi cal and physical factors could affect CPC migration. A cell physiology study also suggested that purinergic signal ling might be involved in regulating calcium oscillations in migrating CPCs and the subsequent chondrogenic differentiation of these cells. 53 The functional role of the migratory cells is not clearly understood. In the study by Seol et al., 31 migratory cells harvested from the cartilage injury area produced more side populations identified by flow cytometry, and expressed higher levels of IL6 and lower levels of carti lage ECM genes, such as collagen type II and aggrecan, compared with normal chondrocytes. The migratory cells are thus proliferative and exhibit a phenotype dif ferent from chondrocytes. Interestingly, these migratory cells also showed a high level of expression of the PRG4 gene, which encodes lubricin (proteoglycan 4), compared with bonemarrowderived MSCs from the same donor. 31 Lubricin is an important cartilage superficial zone protein responsible for joint lubrication and protection of the articular cartilage surface in the joint cavity. The functions of lubricin in the articular joint also include preventing synovial cell overgrowth and chondro cyte apoptosis. [60] [61] [62] Inflammation reduces lubricin levels in both cartilage and synovium. 62 In vitro and animal experiments showed that injecting lubricin into an injured joint could 'repaint' the joint cavity, including resurfacing of the cartilage tissue, 63 thus delaying joint degeneration. 64 Because PRG4 expression was higher in migratory cells than bonemarrowderived MSCs, these migratory CSPCs probably contribute to the bio logical resurfacing of cartilage after injury (Figure 2b ).
CSPCs in osteoarthritis
Cell proliferation and stem cell surface markers are increased in OA tissue, evidenced by the finding that the proportion of CD105 + CD166 + cells in OA cartilage was ~8%, compared with ~4% in normal cartilage, 28 suggesting the possible involvement of these cells in OA pathogenesis. Other clues indicate that CSPCs are involved in all stages of OA. In early OA, cell clusters were found in and near the fissures and clefts of the articular carti lage; within these clusters, both anabolic and catabolic markers were detected 12, 51 and most cells expressed Notch1, STRO1 and VCAM1. 30, 51 In proximity to the cell clusters, positive staining for these three stem cell markers was also found in the middle zone of OA carti lage. 30, 51 These findings suggest that CSPCs might be involved in ECM remodelling in early OA (Figure 2c ), but more studies are needed to confirm this.
In late OA, Koelling et al. 32 reported a migratory popu lation of chondrogenic progenitor cells in degenerated cartilage sites. These cells were located in areas of tissue repair and could have been local cells or cells that had migrated from neighbouring bone tissue, or both, as the cartilage tidemark was broken and neovasculariza tion underneath the cartilage tissue was evident. 32 This disruption of the cartilage ECM in late OA probably alters the mode and extent of communication between the articular cartilage and the subchondral bone, 65 syn ovium 66 and other neighbouring tissues; 67 perhaps these migratory cells could act as a messengercell population that shuttles between tissues (Figure 2d ). The functional roles of CSPCs in the progression of OA are not yet understood, and studies on how these migratory cells interact with the subchondral bone and synovium, and whether they are involved in OA associated pathologies such as osteophyte formation, 68 are clearly needed.
CSPCs in osteoarthritis therapy
Available evidence strongly suggests that the pheno type of CSPCs in OA correlates with the degree of ECM degeneration in the articular cartilage, but the function of these cells remains unclear and is likely to be different at different stages of OA. In early OA, which is marked by loss of the superficial zone and structural changes in the internal matrix despite an increase in cell number and the formation of cell clusters, the cells remain embedded within the ECM (Figure 3a) . 12, 51 In later OA, the matrix undergoes further loss of organization, and the cells seem to be able to migrate freely (Figure 3b) . 32 Thus, any therapeutic strategies that target CSPCs must take into consideration the stagespecific nature of the cells.
In early OA, the main goal of therapeutic strategies is to preserve tissue structure and function. Given the known characteristics of CSPCs, CSPCbased strategies could aim to enhance, for instance, joint resurfacing, ECM pro duction or chondroprotection. Firstly, targeting CSPCs to enhance joint resurfacing would recruit cells producing high amounts of lubricin to generate a new surface layer, thus replacing the degenerated tissue, as discussed above. Secondly, targeting CSPCs to enhance ECM production would promote tissue homeostasis. Although few studies on the metabolic regulation of CSPCs are available, sig nalling molecules such as transforming growth factor β and bone morphogenic proteins are clearly effective in enhancing chondrocyte redifferentiation and ECM pro duction, as shown in studies on isolated CSPCs in vitro. 32 Thirdly, targeting CSPCs to enhance the intrinsic chondro protective ability of these cells through inhibition of matrixdegrading enzymes would induce, for example, the production of tissue inhibitors of metalloproteinases (TIMPs), 69 inhibitors of a disintegrin and metalloprotein ase with thrombospondin motifs (ADAMTS), 70 or anti inflammatory cytokines such as IL1 receptor antagonist (ILRa). 71 Progress in one or more of these directions will help to modulate ECM turnover and delay cartilage degeneration in early OA.
In later stages of OA, the loss of cartilage ECM and the accompanying tissue structural changes result in the formation of channels from the synovium to the subchondral bone, enabling cell passage between these tissues ( Figure 3B ). This scenario necessitates an in depth analysis of the biology of the migratory cellstheir origins, functions and migratory tracks, and the consequences of their migration. Although the migra tory ability of CSPCs is known, the ability of synovial cells, such as synovial fibroblasts, to migrate into the cartilage ECM is unknown. If uncontrolled cell migra tion is a consequence of or accelerates tissue disruption in laterstage OA, blocking cell migration might delay degeneration. On the other hand, if the travelling cells function in tissue rebuilding, cell migration should be promoted. As endstage OA is characterized by cartilage loss and thickening of the subchondral bone, adapting the altered tissue structure to facilitate joint movement is of critical importance, in addition to pain management. Interestingly, in some clinical cases, a very thin, protec tive, cartilagelike layer can be found on the surface of the abnormal subchondral bone; 72 this layer was thought to result from chondrocyte aggregation with accom panying lubricin production, suggesting endo genous jointresurfacing activity. 73 Although the mechanisms responsible for this neocartilage formation in the joint environment of such latestage OA are unknown, the involvement of CSPCs is highly probable and could be a target for OA therapy.
Conclusions
Growing evidence suggests that CSPCs are present in human articular cartilage. Although the lack of a spe cific cell marker prevents in vivo tracing, these cells are characterized by a selfrenewal ability, differentiation multipotency and migration. In cartilage tissue, these cells actively respond to injury and OA, having dif ferent phenotypes in the early and late stages of OA. Understanding the function of CSPCs in vivo at different stages of disease is critical to the design of CSPCbased OA therapies.
Review criteria
We searched the PubMed database for full-text Englishlanguage articles, with a focus on papers published since 2000. Initial searches were broad, using the terms "cartilage progenitor cells", "chondrogenesis", "cartilage stem cells", "chondrocytes", "cartilage cell clusters" and "osteoarthritis". The retrieved papers were evaluated and appropriate articles were selected according to relevant scientific and clinical data.
